Search filters

List of works by James P Morden

A poetic story: lessons learnt from the world's largest breast cancer window of opportunity study.

scientific article published on 16 November 2015

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, c

article

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial

scientific article published on April 2016

Adjusting Survival Time Estimates to Account for Treatment Switching in Randomized Controlled Trials—an Economic Evaluation Context

article

Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial.

scientific article

Analysis techniques in the presence of non-proportional hazards (PH); application to an ovarian cancer RCT with long-term follow-up.

scientific article published on 16 November 2015

Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study.

scientific article

Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation study

scientific article published on January 11, 2011

Benefits and challenges of electronic data capture (EDC) systems versus paper case report forms.

scientific article published on 16 November 2015

Bone marrow micrometastases in early breast cancer-30-year outcome

scientific article published on 14 January 2016

Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study

scientific article published on 20 January 2012

Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: A survey of centres participating in a national randomised controlled trial

scientific article published on 18 November 2013

DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer

scientific article

Design considerations when transitioning from paper case report forms (CRFS) to electronic data capture (EDC).

scientific article

Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane study

scientific article published on 31 October 2011

Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial.

scientific article published on 8 August 2012

Fatigue during chemoradiotherapy for nasopharyngeal cancer and its relationship to radiation dose distribution in the brain.

scientific article published on 13 August 2013

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).

scientific article published in July 2011

Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas

scientific article published on April 2016

Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom

scientific article

Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation

scientific article

Long-Term Follow-Up of the Intergroup Exemestane Study

scientific article published on 3 May 2017

Managing non-proportionality of hazards (PH) within TNT: a randomised phase III trial of carboplatin compared to docetaxel for patients with metastatic or recurrent locally advanced triple negative (TN) or brca1/2 breast cancer (BC).

scientific article published on 16 November 2015

NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer

scientific article published on 14 November 2014

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

scientific article

Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy

scientific article published on 17 March 2016

Reply to S. Kilickap et al, Y. Karakas et al, and I.A. Voutsadakis

scientific article published on 21 March 2016